Day One Biopharmaceuticals · 1 day ago
Join Our Research & Development Community
Maximize your interview chances
BiopharmaBiotechnology
Insider Connection @Day One Biopharmaceuticals
Get 3x more responses when you reach out via email instead of LinkedIn.
Company
Day One Biopharmaceuticals
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Funding
Current Stage
Public CompanyTotal Funding
$687.5MKey Investors
RA Capital Management
2024-07-30Post Ipo Equity· $175M
2023-06-06Post Ipo Equity· $150M
2022-06-14Post Ipo Equity· $172.5M
Recent News
GlobeNewswire News Room
2024-11-21
2024-11-12
Company data provided by crunchbase